The tricks of lymphomas

 

Cellular immunotherapies have so far been only partially effective against non-Hodgkin’s lymphoma. A team led by Armin Rehm of the MDC has discovered a possible reason. As they describe in “Cell Reports”, this cancer induces changes in the large…

3 Min
More

Charité develops a ‘Health Data Cloud‘ with EBRAINS to help shape the European Health Data Space

EBRAINS, the new digital research infrastructure developed by the EU-funded ‘Human Brain Project’, has been included in the 2021 Roadmap of the European Strategy Forum on Research Infrastructures (ESFRI). EBRAINS’ goal is to use digital methods and…

2 Min
More

Eckert & Ziegler Acquires Property for Radiopharmaceutical Production Site in China

 

Berlin, 5 November 2021. Eckert & Ziegler AG (ISIN DE0005659700), a global specialist for isotope applications in medicine and industry has acquired an approximately 7,000 m² property with an expansion option for the building of its Chinese…

2 Min
More

Sanity Group Closes $3.5M Follow-On Investment by Casa Verde Capital

November 3, 2021, Berlin – Berlin-based cannabis start-up Sanity Group announced today it has closed a $3.5M follow-on investment from Casa Verde Capital, representing a second closing of the company’s $45M Series A financing round. This brings total…

2 Min
More

New Berlin Cell Hospital announced

When cells make the wrong decision, diseases ensue. This insight came from Berlin – namely from Rudolf Virchow, whose 200th birthday is being celebrated this year. To mark the anniversary, Berlin research institutions have announced the founding of…

4 Min
More

mediaire wins international MICCAI-challenge on MS lesion segmentation

In this prestigious challenge 24 teams from all over the world submitted their algorithms and pipelines to find out who can detect new MS lesions best. mediaire’s pipelines made it to the top (rank 1 & 3)!

 

1 Min
More

Nature article: SARS-CoV-2 disrupts timing of immune response

Once an infection is under control, the body normally uses a biochemical messenger known as TGFβ to downgrade its immune response. In severe COVID-19, however, this messenger is released at the very beginning of the infection, thus blocking the early…

5 Min
More

Berliner Startup Stipendium – New call for a Sustainable City

You have an idea that needs to become reality? Your research could make this world a better place if turned into a product or service? Science & Startups and our network partners TU, HU, FU and Charité will help you along your journey!

2 Min
More

Eckert & Ziegler Acquires 53,000 Square Feet Facility for Expansion of Contract Development and Manufacturing Services

Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) has received from the Berlin City Government a 66-year long-term lease for an industrial property with 53,000 square feet (5,000 square meters) of factory floor located at…

2 Min
More

ASC Oncology expands into Switzerland and the United Kingdom and makes the Reverse Clinical Engineering® testing procedures easily accessible to oncologists and patients

 

Berlin, August 13, 2021 -With the foundation of ASC Oncology Schweiz AG, cancer patients with malignant solid tumors and their treating oncologists can now also use a new test procedure in Switzerland. With the help of the Reverse Clinical…

2 Min
More
Show more items